ArticlePediatric nephrology (Berlin, Germany)2005

Rituximab treatment for posttransplant lymphoproliferative disorder (PTLD) induces complete remission of recurrent nephrotic syndrome.

Kandai Nozu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.